GRACE is pleased to announce the acceptance of two rising stars in to the inaugural GRACE Fellows Ambassador Program for the 2019-2020 Program Year! Both candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content which will be featured on the GRACE website, working alongside GRACE faculty, Board and staff, and learning the most current and effective communication skills needed...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
Did you recently receive a diagnosis of non small cell lung cancer? GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lung cancer experts listed below. David R. Gandara, MD Melissa L. Johnson, MD Suresh S. Ramalingam, MD Heather Wakelee, MD H. Jack West, MD
Genetic Testing - Navigating the Insurance Process The oncology field is constantly innovating and changing, and in response so are testing methods to determine the location of the cancer, monitor progression, and metastases, and most recently to determine the most effective treatment option. Typically, when monitoring your cancer or determining progression your oncologist may order either a tissue biopsy or a liquid biopsy. A standard tissue biopsy is when the specimen is taken directly from...